INTRODUCTION
Staphylococcus aureus colonizes the moist squamous epithelium in the anterior nares of about 20 % of the human population and is a transient resident of another 60 %. The bacterium is an important aetiological agent of human infections such as endocarditis, osteomyelitis and septic arthritis. Nasal colonization is an important risk factor for the pathogenesis of infection (Cole et al., 2001; Kluytmans et al., 1997; Peacock et al., 2001) . The ability to adhere to host surfaces is a prerequisite for colonization and initiation of the infection process. S. aureus can bind a multitude of host extracellular matrix proteins including fibrinogen, fibronectin, collagen, elastin and von Willebrand factor. Adherence to these host proteins is mediated by a group of staphylococcal surface proteins termed MSCRAMMs (microbial surface components recognizing adhesive matrix molecules) (Foster & Höök, 1998) .
The majority of MSCRAMMs are covalently linked to peptidoglycan and are characterized by common features including an N-terminal signal sequence and a C-terminal region comprising an LPXTG motif involved in covalent linkage to peptidoglycan, a stretch of hydrophobic residues and a short charged tail (Navarre & Schneewind, 1999) . S. aureus possesses 21 genes with potential to encode proteins possessing a C-terminal cell-wall-sorting signal (Mazmanian et al., 2001; Roche et al., 2003) . Eleven encode known proteins, some of which have been characterized in detail at the structural and functional level. These include the fibronectin-binding proteins FnbpA and FnbpB, which additionally bind to fibrinogen, the collagen-binding protein Cna, protein A, which binds IgG and von Willebrand factor, and the fibrinogen-binding clumping factors A and B (ClfA and ClfB) (reviewed by Foster & Höök, 1998; Wann et al., 2000) .
We recently investigated the molecular basis of adherence of S. aureus to human desquamated nasal epithelial cells, a phenomenon which is likely to be important in nasal colonization. ClfB was shown to be an important adhesin mediating attachment of S. aureus to these cells. Furthermore, the ligand for ClfB-mediated adhesion was identified as type I cytokeratin 10, which was shown to be exposed on the surface of epithelial cells (O'Brien et al., 2002).
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Ten genes encoding previously uncharacterized S. aureus surface (Sas) proteins were identified from genome sequences (Roche et al., 2003) . One of these (SasG) has significant sequence identity to two previously documented staphylococcal proteins, namely, Pls of S. aureus and AAP of Staphylococcus epidermidis. SasG possesses an N-terminal region A which comprises a unique 157-residue subdomain and a conserved 212-residue subdomain which is 52 and 59 % identical to similar domains in protein Pls of S. aureus and AAP of S. epidermidis, respectively ( Fig. 1 ; Hussain et al., 1997; Savolainen et al., 2001) . The A domain of SasG is followed by 128-residue B repeats which are also related to repeats of Pls (65 % identity) and AAP (60-67 % identity) (Fig. 1) .
In this study, we have investigated the ability of SasG to promote adhesion of bacterial cells to desquamated nasal epithelial cells by expressing SasG on the surface of the surrogate host Lactococcus lactis. We analysed the in vitro expression of SasG by S. aureus but could only detect protein when the sasG gene was present on a multicopy plasmid. We also investigated the ability of Pls and AAP to interfere with SasG-promoted adherence. We propose that SasG, Pls and AAP represent a family of proteins which bind to a common receptor on the surface of nasal epithelial cells and that these proteins are adhesins which, in addition to ClfB, promote binding of S. aureus to nasal epithelial cells.
METHODS
Bacterial strains and growth conditions. Lactococcus lactis MG1363 was used for heterologous expression of SasG (Gasson, 1983) . The plasmid expression vector used was pKS80, a derivative of pTREX1 (Hartford et al., 2001; Wells & Scholfield, 1996) . L. lactis was grown at 30 uC for 16 h on M17 agar or broth (Difco) containing 0?5 % (w/v) glucose. S. aureus strains were grown in brain-heart infusion (BHI; Oxoid) or tryptic soya broth (TSB; Difco). Stationaryphase cultures were grown for 16 h at 37 uC. Exponential-phase cultures were grown for 2 h from an initial inoculum of 1 : 100 diluted washed stationary-phase cells. For sessile growth, S. aureus was grown on BHI agar. S. aureus strains used in this study were 8325-4 (Novick, 1967) , COL [sequenced at TIGR (http://www. tigr.org/); Shafer & Iandolo, 1979] and MSSA [sequenced at The Sanger Institute (http://www.sanger.ac.uk/projects/S_aureus); Enright et al., 2000] . Escherichia coli strains TOPP 3 (Stratagene) and M15 (Qiagen) used for expression of recombinant hexahistidine (His 6 )-tagged proteins were grown in Luria broth (LB) or on L-agar. Where appropriate, media were supplemented with ampicillin (100 mg ml 21 ), chloramphenicol (10 mg ml 21 ), erythromycin (5 mg ml
21
) and IPTG (1 mM).
Expression of Sas proteins by L. lactis MG1363 and S. aureus 8325-4. The sasG gene was amplified by PCR using Pfu polymerase. S. aureus 8325-4 genomic DNA was used as template. The forward and reverse primers used are outlined in Table 1 . The single PCR product was purified, cut with BclI and cloned into the BclI site of the L. lactis expression vector pKS80. The recombinant plasmid was transformed into competent L. lactis MG1363 cells by electroporation as described previously (Hartford et al., 2001; Wells et al., 1993) . Transformants were selected on M17 agar containing glucose and erythromycin. Transformants were screened for protein expression by whole-cell Western immuno-dot blotting using specific antibodies to the SasG protein.
To introduce pKS80 : : sasG into S. aureus 8325-4, purified pKS80 : : sasG plasmid DNA was firstly transformed into S. aureus RN4220 by electroporation and erythromycin-resistant recombinants were selected. pKS80 : : sasG was subsequently transduced into S. aureus 8325-4 using bacteriophage 85 .
Expression of Pls by S. aureus 8325-4. The recombinant pCU1 plasmid expressing pls (pPLS4) has been described previously (Savolainen et al., 2001) . pPLS4 was transformed into S. aureus RN4220 by electroporation and chloramphenicol-resistant recombinants were selected. pPLS4 was subsequently transduced into S. aureus 8325-4 using bacteriophage 85.
Construction and purification of recombinant His 6 -tagged fusion proteins. The recombinant pQE30 plasmid expressing His 6 -tagged rSasG 52-428 was constructed as described previously (Roche et al., 2003) . E. coli TOPP 3 expressing rClfB 44-542 was a kind gift from Dr E. Walsh, Department of Microbiology, Trinity College, Dublin, Ireland (Perkins et al., 2001) . Gene fragments encoding other recombinant subdomains of SasG, Pls and AAP were generated by PCR using Pfu polymerase. The forward and reverse primers are detailed in Table 1 . The templates used to amplify sasG, pls and aap gene fragments were S. aureus 8325-4 genomic DNA, pPLS4 (Savolainen et al., 2001) and S. epidermidis RP62A genomic DNA, respectively. PCR products were cleaved at appropriate restriction sites for directional cloning, cloned into pQE30 and transformed into E. coli. E. coli TOPP 3 was used for expression of all recombinant proteins, with the exception of rSasG where E. coli M15 (Qiagen) was used.
For expression of recombinant B repeats (SasG Brep ), the primers were designed to anneal to DNA outside that specifying the B repeats. PCR amplification resulted in the generation of a series of products corresponding to a different number of B repeats. This phenomenon is due to repeat-length variation caused by recombination occurring between the highly homologous B repeat DNA (Roche et al., 2003) . The mixed PCR products of the B repeat region were cloned into pQE30, and one resultant E. coli transformant was used in the present studies. -affinity and ion-exchange chromatography in the presence of protease inhibitors (Roche incomplete protease inhibitor cocktail) as described by Perkins et al. (2001) . The purified proteins were finally dialysed against PBS (10 mM phosphate buffered salts, 138 mM NaCl, 2?7 mM KCl), concentrated by ultrafiltration and stored at 275 uC. Protein concentration was estimated by the Bio-Rad protein assay using BSA as standard. Mass spectrometry was performed by Dr Richard Turner, Department of Biochemistry, University of Cambridge, UK.
Bacterial adherence to epithelial cells. Adherence assays were performed as described previously (O'Brien et al., 2002) . Briefly, this involved harvesting epithelial cells from healthy donors by vigorous swabbing of either the epithelium of the nasal septum (nasal epithelial cells) or the buccal epithelium (buccal epithelial cells) followed by washing of the cells with PBS. Immortalized HPV-G keratinocytes from human foreskin were cultured in DMEM-F 12 medium as described previously (O'Brien et al., 2002; Pirisi et al., 1988) . For adherence assays, keratinocytes were removed from flasks by scraping into incomplete medium, washing in incomplete medium and disaggregation by passage through a 26-GA needle. Washed epithelial and keratinocyte cells were then quantified and adjusted to 56 10 4 cells ml 21 . Bacterial cells were washed with PBS and adjusted to 1610 9 c.f.u. ml 21 . Fifty-microlitre volumes of bacterial and epithelial cells were mixed and incubated at 37 uC for 1 h with occasional shaking. Mammalian cells with adherent bacteria were then harvested onto 12 mM isopore polycarbonate filters, washed with PBS, fixed and stained with 5 % crystal violet. The polycarbonate filters were then mounted onto glass slides and the number of bacteria adherent to 100 epithelial or keratinocyte cells was determined by visual counting using light microscopy.
For blocking experiments, 50 ml volumes of epithelial cells (adjusted to 5610 4 cells ml 21 ) were incubated for 20 min at 37 uC with 10 ml volumes of protein solutions of varying concentrations. Final protein concentrations were in the range 0?008-1?0 mM. Bacterial cells were then incubated with these treated epithelial cells for 1 h at 37 uC and the adherence assay was continued as described above. Blocking experiments performed using 1?0 mM proteins were performed four times in duplicate. Inhibition curves were performed twice in duplicate.
Ligand-binding experiments. Experiments to measure adherence of L. lactis and S. aureus cells to immobilized ligands were performed as described previously (Hartford et al., 1997) . Briefly, 96-well flat-bottomed plates were coated with increasing concentrations of matrix proteins in PBS overnight. After blocking with 2 % (w/v) BSA, the wells were incubated at 37 uC for 2 h with 100 ml volumes of bacterial cells (OD 600 of 1?00). Adherent cells were then fixed with formaldehyde, stained with crystal violet and the level of adherence quantified by measuring absorbance at 570 nm.
Preparation of anti-SasG antibodies. Antibodies to rSasG were raised in New Zealand White rabbits and partially purified by a number of dialysis steps as described previously (Owen, 1985) . The antibodies were then purified using a number of affinity steps. The anti-SasG antibodies were firstly purified on a SasG-affinity column. This involved covalent linkage of purified His 6 -tagged rSasG 52-428 to a HiTrap NHS-activated HP column as described by the manufacturer (Amersham Biosciences). Crude antiserum was passed through the affinity column and bound anti-SasG antibodies were eluted with 0?1 M glycine, pH 2?5. Following dialysis against PBS, antiSasG antibodies were then passed through an E. coli lysate column (Pierce) to remove any cross-reacting E. coli antibodies. In order to remove antibodies to the His 6 tag, the SasG antibodies were finally passed through an affinity column prepared using an unrelated His 6 -tagged protein (SdrD). The purified antibody was concentrated 10-fold relative to the initial volume of serum and finally dialysed against PBS containing 15 mM sodium azide.
Preparation of and Western blot analysis of enzymic extracts of S. aureus and L. lactis. Cell-wall-associated proteins of S. aureus and L. lactis cells were prepared as described previously (Hartford et al., 2001; Roche et al., 2003) . Briefly, washed bacterial cells were resuspended (OD 600 of 40) in lysis solution [20 mM Tris/ HCl pH 7?5 containing 20 mM MgCl 2 , 30 % (w/v) raffinose and Roche incomplete protease inhibitor cocktail]. S. aureus cells were extracted by incubation for 30 min at 37 uC in the presence of lysostaphin (200 mg ml 21 ). L. lactis cells were extracted for 10 min at 37 uC in mutanolysin (500 U ml 21 ) and lysozyme (400 mg ml 21 ). S. aureus and L. lactis protoplasts were finally recovered by centrifugation at 7000 g for 15 min. Ten-microlitre volumes of the supernatant fractions were boiled for 5 min in Laemmli sample buffer prior to SDS-PAGE on either 10 % (w/v) or 12?5 % (w/v) polyacrylamide separating gels (Laemmli, 1970) . Molecular mass markers (Gibco-BRL, BenchMark protein ladder or New England Biolabs prestained protein markers) were also included on the SDS-PAGE gels. SDS-PAGE gels were stained with Coomassie brilliant blue or electrotransferred onto PVDF membranes (Roche Molecular Biochemicals). The blots were blocked overnight at 4 uC in 5 % (w/v) dried skimmed milk (Marvel). The rabbit antibodies used to probe the blots were anti-SasG (1 : 20 000), anti-ClfA A domain (1 : 1000; a gift from J. Higgins, Department of Microbiology, Trinity College, Dublin, Ireland) or anti-FnbpA A domain (1 : 200; a gift from F. Keane, Department of Microbiology, Trinity College, Dublin, Ireland). Bound antibodies were detected with protein A-peroxidase (1 : 2000; Sigma). The Western blots were finally developed using chemiGLO (New England Biolabs) and visualized by exposure to X-ray film.
RESULTS

Expression of SasG by S. aureus and L. lactis
The sasG gene of S. aureus 8325-4 was amplified by PCR, cloned into the expression vector pKS80 and transformed into the surrogate Gram-positive host L. lactis. Western immunoblotting with affinity-purified anti-SasG 52-428 antibodies was used to analyse expression of SasG in L. lactis (Fig. 2) . S. aureus strain 8325-4 was also tested, along with S. aureus 8325-4(pKS80 : : sasG). These experiments revealed one major immunoreactive band migrating at an apparent molecular mass of 220 kDa for L. lactis MG1363(pKS80 : : sasG) (Fig. 2, lane 1) . This immunoreactive band was absent in L. lactis MG1363(pKS80). No immunoreactive SasG protein was detected in S. aureus 8325-4 (Fig. 2, lane 4) . However, expression of SasG was observed when S. aureus was transformed with pKS80 : : sasG (Fig. 2, lane 3) .
In an attempt to identify conditions under which SasG is expressed in vitro, strains 8325-4, COL and MSSA were grown to exponential phase and stationary phase in TSB and BHI broth and on the surface of BHI agar plates before preparing cell-wall extracts for Western immunoblotting. However, no immunoreactive band was ever detected.
The anti-SasG antibodies can detect as little as 0?75 ng of protein in Western immuno-dot blot experiments (data not shown). The failure to detect SasG in wild-type S. aureus grown under in vitro conditions indicates very low levels of expression. Therefore, in order to conduct meaningful functional analysis of SasG, we studied L. lactis and S. aureus 8325-4 expressing SasG from pKS80, and purified recombinant SasG proteins.
Ligand binding
To identify a possible ligand for SasG, adherence assays were conducted. L. lactis MG1363(pKS80 : : sasG) was tested for its ability to adhere to immobilized fibrinogen, fibronectin, human epidermal keratin, collagen, von Willebrand factor, laminin, heparan sulfate and submaxillary mucin. No adherence to any of these ligands was observed (data not shown).
SasG promotes adherence to desquamated nasal epithelial cells
ClfB has recently been shown to promote adherence of S. aureus and L. lactis to desquamated nasal epithelial cells mediated by its interaction with cytokeratin 10. A clfBnegative mutant of S. aureus 8325-4 exhibited a slight but significant reduction in adherence to cytokeratin 10 and squamous cells (O'Brien et al., 2002) suggesting that other surface factors are involved. To test whether SasG may play a role in adherence, L. lactis MG1363(pKS80 : : sasG) cells were tested for their ability to adhere to squamous epithelial cells isolated from the anterior nares of healthy individuals. Whereas L. lactis MG1363(pKS80) adhered poorly, L. lactis expressing SasG exhibited significant adherence to squamous cells (P=0?001; Fig. 3 ). These data suggest that SasG promotes adherence to squamous nasal cells through a specific receptor-ligand interaction. Further support for this comes from analogous adherence assays conducted using S. aureus, where it was shown that S. aureus 8325-4 (pKS80 : : sasG) exhibited a 1?7-fold increase in adherence to squamous cells compared to S. aureus 8325-4 (P=0?0001) (Fig. 3) . In these experiments, stationary-phase-grown S. aureus cells were used which express very low levels of ClfB (McAleese et al., 2001; Ní Eidhin et al., 1998) . This eliminates any bacterial adherence promoted by ClfB.
The ability of SasG to promote binding to buccal epithelial cells isolated from healthy donors and to an immortalized keratinocyte cell line was also tested. The results of these experiments showed that there was negligible adherence of L. lactis MG1363(pKS80 : : sasG) to keratinocytes and buccal cells. The counts of L. lactis MG1363(pKS80 : : sasG) per 100 keratinocytes and buccal cells were 31±25 and 40±19, respectively. This was similar to the low background binding of L. lactis MG1363(pKS80) to keratinocytes (11±10 bacteria per 100) and buccal cells (36±23 bacteria per 100).
Recombinant A region of SasG inhibits binding of L. lactis expressing SasG to nasal epithelial cells
To confirm that the interaction of SasG with nasal epithelial cells was specific and to identify the region of SasG involved in binding, experiments were carried out to test whether pre-incubation of epithelial cells with recombinant truncated variants of SasG could block adherence of L. lactis MG1363(pKS80 : : sasG). DNA encoding the A region (residues 52-428), the unique A region subdomain (residues 52-207), the conserved A region subdomain (residues 207-428) and B repeats ( Fig. 1) were amplified by PCR and cloned into the expression vector pQE30 which places a histidyl affinity tag at the N terminus. The resultant recombinant proteins were purified from E. coli by metal chelate chromatography. All three proteins gave a single dominant band on SDS-PAGE gels (data not shown). Mass spectrometry showed the recombinant proteins were of the anticipated molecular masses (viz. rSasG ) or B repeats did not inhibit adherence (Fig. 4) . These results provide further support for our contention that SasG binds to squamous nasal epithelial cells and also suggests that the A region but not the B repeat region of the protein is involved in promoting bacterial adherence.
Recombinant A regions of Pls and AAP inhibit adherence of L. lactis expressing SasG to nasal epithelial cells
SasG protein possesses significant sequence similarity and has similar domain organization to Pls and AAP (Fig. 1) . In particular a 212/217 residue domain is conserved within the A regions of the three proteins. It was of interest, therefore, to determine whether, like SasG, the A regions of Pls and AAP could also block SasG-promoted bacterial attachment to squamous epithelial cells. PCR-amplified pls and aap sequences encoding the A regions were therefore cloned into the expression vector pQE30 and the recombinant proteins purified by metal chelate chromatography. The purified proteins gave a single dominant band on SDS-PAGE gels and the anticipated molecular masses (viz. rPls , 71 219 Da; rAAP 53-608 , 60 504 Da) when analysed by mass spectrometry.
Pre-incubation of nasal epithelial cells with the purified A regions of Pls and AAP inhibited L. lactis MG1363 (pKS80 : : sasG) binding in a dose-dependent manner (Fig. 5) . In contrast, control experiments where epithelial cells were pre-incubated with recombinant ClfB N1-3 , a protein known to bind cytokeratin 10 on the surface of these cells (O'Brien et al., 2002) , did not affect L. lactis MG1363(pKS80 : : sasG) binding. L. lactis MG1363 (pKS80 : : sasG) showed 95 % binding to epithelial cells following pre-incubation with 1 mM ClfB. These experiments suggest that Pls and AAP bind to squamous nasal epithelial cells and that they probably recognize the same epithelial cell receptor as SasG.
Pls promotes bacterial adherence to desquamated nasal epithelial cells
The blocking experiments described above using purified recombinant protein provide good evidence that Pls binds to nasal epithelial cells. To confirm that the protein can promote bacterial attachment to epithelial cells, the adherence of S. aureus 8325-4, which does not possess pls, was compared to strain 8325-4(pPLS4), which expresses a high level of Pls (Savolainen et al., 2001) . These experiments showed that S. aureus 8325-4(pPLS4) exhibited a 1?6-fold increase (P=0?0001) in adherence as compared to strain 8325-4 (Fig. 3) . This suggests that Pls can promote bacterial attachment to nasal epithelial cells.
Like SasG, Pls did not promote bacterial binding to either buccal epithelial cells or to cultured keratinocytes. The counts of S. aureus 8325-4(pPLS4) per 100 keratinocytes and buccal epithelial cells were 43±9 and 208±57, respectively. This was not significantly different to that of S. aureus 8325-4 adherence to keratinocytes and buccal cells where the bacterial counts per 100 cells were 44±15 and 204±19, respectively.
SasG expression prevents adhesion of S. aureus to fibrinogen and fibronectin
It was previously shown that expression of Pls prevented S. aureus from binding to fibronectin, fibrinogen, IgG and BSA (Hildén et al., 1996; Savolainen et al., 2001) . To determine whether SasG possesses masking ability, adherence of S. aureus 8325-4 to fibrinogen and fibronectin was measured and compared to S. aureus 8325-4(pKS80 : : sasG) and to S. aureus 8325-4(pPLS4). These tests were performed for S. aureus cells grown to both the stationary phase and exponential phase of growth. S. aureus shows a growthphase-dependent expression of surface proteins. Therefore, in the stationary phase of growth, the fibrinogen-binding protein ClfA and not ClfB or the fibronectin-binding proteins (FnbpA and FnbpB) would be expressed. In contrast, all four proteins would be expressed in the exponential phase of growth (McAleese et al., 2001; Ní Eidhin et al., 1998; Saravia-Otten et al., 1997) . The results of the adherence assays showed that S. aureus 8325-4 adhered to fibrinogen and fibronectin in a dose-dependent fashion.
In contrast, S. aureus 8325-4(pPLS4) did not adhere to either ligand. Importantly, S. aureus 8325-4(pKS80 : : sasG) showed a significant reduction in binding to both ligands (Fig. 6a, b) . The profile of binding of exponential-phase cells to fibrinogen was similar to that observed for fibronectin (data not shown). Masking of ligand binding was greater in cells from stationary phase than in cells from exponential phase. SDS-PAGE analysis of solubilized cell-wall-associated proteins showed that the level of Pls was much higher than SasG (Fig. 6c, lanes 2 and 3) . The apparent breakdown of Pls protein was observed previously (Hildén et al., 1996; Savolainen et al., 2001) . One reason for the incomplete masking by the SasG + strain could be the lower level of expression of SasG compared to Pls. Certainly, reduced adherence was not due to a reduction in expression of adhesins since Western immunoblotting showed that the fibrinogen-binding ClfA and fibronectin-binding FnbpA proteins were expressed at similar levels in each strain (Fig. 6d, e) .
DISCUSSION
SasG was originally identified as a potential MSCRAMM and adhesin by in silico analysis of staphylococcal genome sequences (Mazmanian et al., 2001; Roche et al., 2003) . The likely importance of SasG in disease was suggested by the observation that sasG was significantly associated with invasive disease-causing strains compared to nasal carriage strains. Furthermore, levels of antibodies to SasG protein were higher in sera from many patients who had recovered from S. aureus infections (Roche et al., 2003) . Here, we show that SasG could promote bacterial binding to squamous nasal epithelial cells. We also provide evidence that Pls and AAP, which exhibit strong homology and similar domain organization to SasG, may also bind to the same epithelial cell receptor.
Our failure to detect SasG expression by S. aureus cells would appear not to be due to degradation of the protein since a high molecular mass immunoreactive protein could be detected when the sasG gene was expressed by pKS80. The fact that sera from patients recovered from S. aureus infections reacted with SasG strongly suggests that the protein is expressed in vivo (Roche et al., 2003) . Using the expression plasmid pKS80, SasG was successfully surface-expressed in a full-length and undegraded form on both S. aureus and the surrogate host L. lactis. For both S. aureus and L. lactis, the lysostaphin-and mutanolysin-solubilized SasG protein ran at an apparent molecular mass of 220 kDa, higher than its molecular mass (179 kDa) predicted from sequence, a feature characteristic of many cell-wall-associated proteins.
Nasal carriage of S. aureus is considered to be a key risk factor for development of staphylococcal infection in the community and hospital (Kluytmans et al., 1997; Peacock et al., 2001) . The main region of the nasal vestibule where colonization occurs is the moist squamous epithelium which is devoid of hair, cilia and microvilli, a region immediately distal to the anterior hairy epidermis (Cole et al., 2001) . In vitro studies have shown that S. aureus cells adhere to desquamated nasal epithelial cells isolated from this region of the nasal vestibule (Aly et al., 1977; Bibel et al., 1982; O'Brien et al., 2002) . O'Brien et al. (2002) showed that ClfB promoted staphylococcal binding to nasal epithelial cells. However, significant binding occurred in clfB mutants indicating that other bacterial factors are involved. In this study, we have shown that S. aureus and L. lactis expressing SasG adhered significantly to nasal epithelial cells in contrast to control bacteria.
Previous studies showed that sasG is more significantly associated with invasive isolates than carriage isolates (Roche et al., 2003) . As individuals are usually infected with their own carriage isolate (Luzar et al., 1990; Yu et al., 1986) it could be speculated that SasG facilitates transmission from the nose to other body sites. Alternatively, SasG may bind to receptors on other mammalian cell types, facilitating colonization elsewhere. Also, SasG could impede opsonophagocytosis. Höök, 1998). The fact that the A regions of Pls and AAP also bound squamous cells strongly implicates the conserved subdomain in ligand binding. However, this region of SasG (residues 207-428) when expressed alone did not inhibit SasG-promoted bacterial adherence to squamous nasal cells. This suggests that additional residues from within the A region are required for function. One likely role for the B repeats could be to act as a stalk to project the ligandbinding A region of the protein away from the cell surface. Such a function has been proposed for the serine-aspartate (SD) dipeptide repeats of the Sdr family and the B repeats of SdrD (Hartford et al., 1997; Josefsson et al., 1998) .
SasG has significant sequence similarity and structural organization to Pls and AAP. Pls is specifically associated with the Type I staphylococcal cassette chromosome mec (SCCmec) mobile genetic element (Heusca et al., 2002; Savolainin et al., 2001) . AAP is associated with the accumulation phase of S. epidermidis biofilm formation (Hussain et al., 1997) . Here, we provide strong evidence that the proteins are functionally related. The fact that Pls and AAP inhibited L. lactis expressing SasG binding to nasal epithelial cells indicates that they are likely to bind to the same mammalian cell receptor. Significantly, S. epidermidis is one of the most common inhabitants of the nares (Lina et al., 2003) . The possibility that AAP and SasG bind to the same receptor on the surface of squamous nasal epithelial cells suggests that competition for binding may occur. Certainly, bacterial interference between different strains of S. aureus and different bacterial species has been shown to affect S. aureus carriage (reviewed by Peacock et al., 2001) . However, several surface components of S. aureus are involved in binding to the squamous epithelium and competition for binding to one receptor is unlikely to be the single determining factor for colonization.
AAP and Pls have both been implicated in promoting bacterial cell-cell interactions (Huesca et al., 2002; Hussain et al., 1997; Savolainen et al., 2001) . SasG also causes cellular aggregation since L. lactis cells expressing SasG form aggregates whereas wild-type L. lactis cells do not (F. M. Roche, M. Meehan & T. J. Foster, unpublished data). The ability to form aggregates could be advantageous in promoting colonization of the surface of epithelial cells.
Another property attributed to Pls is masking the adhesive functions of other MSCRAMMs. Savolainen et al. (2001) showed that adherence to fibronectin and IgG was greatly increased in a S. aureus Pls 2 mutant compared to the isogenic wild-type strain. If such a phenomenon occurs in vivo for Pls, and possibly SasG and AAP, it could be speculated that, at certain points in infection, expression of these proteins may alter staphylococcal adherence characteristics allowing tropism for certain tissue types. In this study, we have shown that SasG also reduced adherence of S. aureus to fibrinogen and fibronectin compared to wildtype. In contrast, Pls-expressing S. aureus failed to adhere to either ligand. The difference in masking could be attributed to the lower level of expression of SasG compared to Pls.
The identity of the mammalian cell receptor for SasG is unknown. Certainly, bacteria have exploited a multitude of host-cell surface components as receptors for adhesins and invasins, including (glyco)proteins, (glyco)lipids and proteoglycans. The fact that SasG does not bind to either buccal cells or non-differentiated keratinocytes would suggest that the receptor for SasG is restricted to desquamated epithelial cells. Our ligand-binding experiments and inhibition experiments suggest that the ligand is not keratin, mucin or heparan sulfate. One candidate receptor for SasG could be ceramides which are present on the cornified envelope of desquamated epithelial cells (Kalinin et al., 2001) . Huesca et al. (2002) provided evidence that Pls binds to lipids and glycosphingolipids including those purified from a keratinocyte cell line. In our hands, Pls did not promote bacterial binding to undifferentiated keratinocytes. However, lipid receptors may be masked in these cells. Experiments to elucidate the identity of the receptor for SasG are currently in progress. Elucidating the factors involved in determining nasal colonization could aid in the future development of novel therapeutics to control nasal and skin colonization and hence staphylococcal infection.
